20273 results for «»

Filter By

20273 results

TARGET FFR: A randomized trial of physiology-guided PCI optimization

19 Oct 2020

At TCT Connect 2020, Damien Collison presented the results of the TARGET FFR trial. Carlos Collet provides a summary of the key messages.

Carlos Collet

Author

Carlos Collet
Live from TCT Connect 2020: The TARGET FFR trial

STS/ACC TVT Registry: Cerebral embolic protection and TAVR outcomes

19 Oct 2020

At TCT Connect 2020, David J. Cohen (Kansas City, Missouri, USA) presented results from an analysis of the TVT registry focusing on impact of Cerebral Embolic Protection (CEP) on TAVR outcomes. Nicolas Dumonteil provides a summary of the key messages.

Author

Nicolas Dumonteil
Live from TCT Connect 2020: The STS/ACC TVT registry

The DEFINE-FLOW study combined CFR and FFR assessment

19 Oct 2020

At TCT Connect 2020, Nils Johnson presented the results of the DEFINE-FLOW study. Carlos Collet provides a summary of the key messages.

Carlos Collet

Author

Carlos Collet
Live from TCT Connect 2020: The DEFINE-FLOW study

IREMMI: Outcomes of MitraClip in patients with acute mitral regurgitation in AMI with and without cardiogenic shock

17 Oct 2020

At TCT Connect 2020, Rodrigo Estevez-Loureiro presented the results of the IREMMI trial. Nicole Karam provides a summary of the key messages.

Author

Nicole Karam
Live from TCT Connect 2020: The IREMMI trial

Low risk TAVI trials in the real world: where are we in 2020?

26 Jun 2020 – From PCR e-Course 2020

Watch this case discussion if you want to fully appreciate the impact of the low risk TAVI trials, to understand how to apply this information in your daily clinical practice and to translate clinical trial outcomes into real-world decisions by your Heart Team.

This session was originally...

Low risk TAVI trials in the real world: where are we in 2020?

TAVI and the conduction system

27 Jun 2020 – From PCR e-Course 2020

Watch this case discussion if you want to appreciate the factors that predict conduction abnormalities during TAVI (and how to avoid them), to understand which patients are at risk of late abnormalities and need prolonged monitoring after TAVI and to identify which patients require permanent pacemaker...

TAVI and the conduction system

Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome

06 Oct 2020

Daniele Giacoppo

Reviewer

Daniele Giacoppo
Prasugrel-based de-escalation of DAPT after PCI in patients with ACS

Prognostic impact of residual anatomic disease burden after functionally complete revascularization

07 Oct 2020

This registry-based study evaluated the clinical outcomes of patients who underwent functionally complete revascularisation as assessed by post PCI FFR >0.80 at two years according to Residual Syntax Scores.

Nicola Ryan

Reviewer

Nicola Ryan
Prognostic impact of residual anatomic disease burden after functionally complete revascularization

Comparison between OFR and QFR

06 Oct 2020

The aim of this study was to evaluate the diagnostic performance of OCT-based optical flow ratio (OFR) in unselected patients and compare it with angiography-based quantitative flow ratio (QFR), using wire-based FFR as reference standard.

Authors :

J. Huang, H. Emori, D. Ding, T. Kubo, W. Yu, P. Huang, S. Zhang, J. L. Gutiérrez-Chico, T. Akasaka, W. Wijns, S. Tu
EuroIntervention: Comparison between OFR and QFR

Hotlines and innovations on valve interventions - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of valve interventions:

  • Safety and efficacy of the TaurusOne TAVR system for aortic stenosis
  • Quantitative angiographic assessment of MR after mitral procedures
Hotlines and innovations on valve interventions - PCR e-Course 2020

How should we use transcatheter mitral valve repair to treat patients with mitral regurgitation?

10 Jun 2021

Watch the replay of this PCR Webinar with N. Van Mieghem, N. Karam and P. Lurz!

How should we use Transcatheter Mitral Valve Repair to treat patients with Mitral Regurgitation

How should we optimally manage mitral and tricuspid regurgitation – the Heart Team approach

22 Feb 2021

[WATCH] - PCR Webinar with M.Metra, B. Prendergast, H. Treede and R. S. Von Bardeleben.

How should we optimally manage mitral and tricuspid regurgitation – the Heart team approach

Hacer Ceren Tokgöz

Istanbul, Türkiye

Hacer Ceren Tokgöz

POPULAR TAVI - Aspirin with or without clopidogrel after TAVI

01 Sep 2020

Reported from ESC Congress 2020 - Mirvat Al Asnag interviews Anna Sonia Petronio (Pisa, Italy) on the results of POPULAR TAVI which showed that in patients not taking oral anticoagulation, aspirin alone compared with aspirin plus clopidogrel following TAVI significantly reduced bleeding rates and did not increase thromboembolic events.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag

Author

Anna Petronio
POPULAR TAVI - Aspirin with or without clopidogrel

BRACE CORONA: Continuing vs. suspending ACE inhibitors and ARBs in COVID-19

01 Sep 2020

Reported from ESC Congress 2020 - Principal Investigator Renato Lopes (Durham, USA) discusses with Luis Ortega-Paz the results of the BRACE CORONA trial revealing that temporarily suspending use of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) did not show clinical benefit in patients hospitalized with mild...

Luis Ortega-Paz

Author

Luis Ortega-Paz
BRACE CORONA: Continuing vs. suspending ACE inhibitors and ARBs in COVID-19

REALITY - A trial of transfusion strategies for myocardial infarction and anemia

03 Sep 2020

ESC Congress 2020: Tabassome Simon (Paris, France) discusses with Francesco Costa the results of REALITY trial which supports the use of a restrictive strategy for blood transfusion in MI patients with anemia.

Francesco Costa

Author

Francesco Costa
REALITY - A trial of transfusion strategies for myocardial infarction and anemia

LoDoCo2 - Low-dose colchicine in coronary disease

02 Sep 2020

Reported from ESC Congress 2020 - Massimo Imazio (Turin, Italy) discusses with Dejan Milasinovic the results of the LoDoCo2 trial which showed that Colchicine reduces the risk of major cardiovascular events in patients with chronic coronary disease.

Dejan Milasinovic

Author

Dejan Milasinovic
LoDoCo2 - Low-dose colchicine in coronary disease

Infolding of a self-expanding bioprosthesis due to loss of nitinol memory during transcatheter aortic valve implantation

28 Jul 2020

A 78-year-old gentleman had transcatheter aortic valve implantation using an Evolut™ R valve. On computed tomography (CT) the perimeter-derived annulus diameter was 29.1 mm. A 34 mm Evolut R was precisely loaded and the same was confirmed fluoroscopically before insertion into the sheath.

Authors :

N. Vasu, A. Chopra, R. Singh Rao, M. Sankardas Ajit
EuroIntervention: Infolding of a self-expanding bioprosthesis during TAVI

Evidence counts: latest Renal Denervation data and the Onyx ONE month DAPT program

19 Oct 2020

On this page you will find a selection of interviews regarding the latest data on renal denervation from TCT Connect 2020, as well as the latest complex sub-analyses from the Onyx ONE Month DAPT program. View a series of short interviews here below!

Evidence counts: latest data from Renal Denervation and the Onyx ONE month DAPT program

What’s new in the 2020 ESC Clinical Practice Guideline on the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (NSTE-ACS)?

29 Aug 2020

Majority of ischemic heart disease patients present with NSTEACS . Management of NSTEACS starts with correct diagnosis, appropriate timely initiation of the right pharmacotherapy, provision of coronary angiography/intervention procedures and secondary preventative care. 5 years on from the last ESC NSTEACS guidelines, what does the new...

Vijay Kunadian

Author

Vijay Kunadian
ESC NSTEACS guidelines 2020
Didn’t find what you were looking for?